Indaptus Therapeutics Statistics
NASDAQ: INDPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.37+0.11 (+4.87%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Indaptus Therapeutics by the numbers
Indaptus Therapeutics has a market capitalization of $315.8 million based on 133.24M shares outstanding. With trailing EPS of $-6.15, Indaptus Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.3% above its 50-day average and 4.2% above its 200-day average.
Average daily trading volume is 829.14K shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INDP valuation vs. peer median
| Metric | INDP | Peer median | Difference |
|---|---|---|---|
| Market cap | $315.78M | $307.29M | +3% |
| Avg. volume | 829.14K | 1.43M | -42% |
Peer median across 8 companies: PRLD, CATX, BNTC, CYPH, RLMD, RCKT, FULC, TTRX.
Valuation
- Market cap
- $315.78M
- EPS (TTM)
- $-6.15
- Shares outstanding
- 133.24M
Price and trading
- Previous close
- 2.26
- Open
- 2.37
- Day range
- 2.29 – 2.53
- 52-week range
- 0.92 – 5.96
- 52-week change
- -38.75%
- Beta
- —
- Volume
- 505.43K
- Average volume
- 829.14K
Dividends and events
- Annual dividend
- None
- Next earnings date
- May 14, 2025
Additional statistics
- Market Cap
- 315.78M
- Forward Pe
- -1.71
- Eps
- -6.15
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.96
- Week52 Low
- 0.92
- Avg Volume
- 829.14K
- Shares Outstanding
- 133.24M
- Ma50
- 1.99
- Ma200
- 2.27
- Earnings Date
- May 14, 2025
- Pct From52w High
- -60.23%
- Pct From52w Low
- 157.61%